Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells

Oncogene

Volumn 16, Issue 12, 1998, Pages 1603-1610

  Capoulade, Corinne ^a   Bressac De Paillerets, Brigitte ^a   Lefrère, Isabelle ^a   Ronsin, Muriel ^a   Feunteun, Jean ^a   Tursz, Thomas ^a   Wiels, Joëlle ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Burkitt's lymphoma; Enhanced translation; MDM2; p53

Indexed keywords

CELL PROTEIN; GENE PRODUCT;

APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CANCER CELL; CELL CYCLE G1 PHASE; CELL GROWTH; CONTROLLED STUDY; GAMMA IRRADIATION; GENE ACTIVITY; GENE AMPLIFICATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RNA TRANSLATION; TUMOR SUPPRESSOR GENE;

EID: 0032568334     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201702     Document Type: Article

References (53)

1. Barak Y, Juven T. Haffner R and Oren M. (1993). EMBO J., 12, 461-468.
2. Berberich S and Cole M. (1994). Oncogene, 9, 1469-1472.
3. Bhatia KG, Gutierrez MI, Huppi K, Siwarski D and Magrath IT. (1992). Cancer Res., 54, 4273-4276.
4. Bornkamm GW, Polack A and Eick D. (1988). c-myc deregulation by chromosomal translocation in Burkitt's lymphoma. In Cellular oncogene activation. G. Klein, (ed) New York: Marcel Dekker, pp. 223-273.
5. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH. (1993). Nature. 362, 849-852.
6. Dulic V, Kaufmann WK, Wilson SJ, Tisty TD, Lees E, Harper JW, Elledge SJ and Reed SI. (1994). Cell, 76, 1013-1023.
7. el-Deiry WS, Tokino T, Velculescu VE, Levy B and Vogelstein B. (1993). Cell, 75, 817-825.
8. Fakharzadeh SS, Trusko SP and George DL. (1991). EMBO J., 10, 1565-1569.
9. Farrell PJ, Allan GJ, Shanahan F, Vousden KH and Crook T. (1991). EMBO J., 10, 2879-2887.
10. Flaman JM, Frebourg T, Moreau V, Charbonnier F, Martin C, Chappuis P, Sappino AP, Limacher IM, Bron L and Benhattar J. (1995). Proc. Natl. Acad. Sci. USA. 92, 3963-3967.
11. Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM and Dalla-Favera R. (1991). Proc. Natl. Acad. Sci. USA, 88, 5413-5417.
12. Haffner R and Oren M. (1995). Curr. Opin. Genet. Dev., 5, 84-90.
13. Haupt Y, Maya R, Kazaz A and Oren M. (1997). Nature, 387, 296-299.
14. Hermeking H and Eick D. (1994). Science. 265, 2091-2093.
15. Hsu B, Marin MC, El-Naggar AK, Stephens LC, Brisbay S and McDonnell TJ. (1995). Oncogene, 11, 175-179.
16. Imamura J, Miyoshi I and Koeffler HP. (1994). Blood, 84, 2412-2421.
17. Jones SN, Roe AR, Donehower LA and Bradley A. (1995). Nature, 378, 206-208.
18. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. (1991). Cancer Res., 51, 6304-6311.
19. Kubbutat MH, Jones SN and Vousden KH. (1997). Nature, 387, 299-303.
20. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB. (1992). Proc. Natl. Acad. Sci. USA, 89, 7491-7495.
21. Landers JE, Haines DS, Strauss JF and George DL. (1994). Oncogene, 9, 2745-2750.
22. Landers JE, Cassel SL and George DL. (1997). Cancer Res., 57, 3562-3568.
23. Lane DP. (1992). Nature, 358, 15-16.
24. Lazar V, Granjouan S, Bognel C, Couturier D, Rougier P, Bellet D and Bressac-de Paillerets B. (1994). Hum. Mol. Genet., 3, 2257-2260.
25. Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, Smith S, Hill DE, Sidransky D, Kinzler KW and Vogelstein B. (1993). Cancer Res., 53, 2231-2234.
26. Levine AJ, Momand J and Finlay CA. (1991). Nature, 351, 453-456.
27. Levine AJ. (1997). Cell, 88, 323-331.
28. Magrath I. (1990). Adv. Cancer Res., 55, 133-186.
29. Marks SI, Kurz BW, Link MP, Ng E, Shuster JJ, Lauer SJ, Brodsky I and Haines DS. (1996a). Blood, 87, 1155-1161.
30. Marks DI, Vonderheid EC, Kurz BW, Bigler RD, Sinha K, Morgan DA, Sukman A, Nowell PC and Haines DS. (1996b). Br. J. Haematol., 92, 890-899.
31. Marks DI, Kurz BW, Link MP, Ng E, Shuster JJ, Lauer SJ, Carroll D, Brodsky I and Haines DS. (1997). J. Clin. Oncol., 15, 1158-1162.
32. Martin K, Trouche D, Hagemeier C, Sorensen TS, La Thangue NB and Kouzarides T. (1995). Nature, 375, 691-694.
33. Metz T, Harris AW and Adams JM. (1995). Cell, 82, 29-36.
34. Miyashita T and Reed JC. (1995). Cell, 80, 293-299.
35. Momand J, Zambetti GP, Olson DC, George D and Levine AJ. (1992). Cell, 69, 1237-1245.
36. Montes de Oca Luna R, Wagner DS and Lozano G. (1995). Nature, 378, 203-206.
37. O'Connor P, Jackman J, Jondle D, Bhatia K, Magrath I and Kohn KW. (1993). Cancer Res., 53, 4776-4780.
38. Oliner JD, Kinzler KW, Meltzer PS, George DL and Vogelstein B. (1992). Nature, 358, 80-83.
39. Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW and Vogelstein B. (1993). Nature, 362, 857-860.
40. Olson DC, Marechal V, Momand J, Chen J, Romocki C and Levine AJ. (1993). Oncogene, 8, 2353-2360.
41. Piette J, Neel H and Maréchal V. (1997). Oncogene, 15, 1001-1010.
42. Preudhomme C, Dervite I, Wattel E, Vanrumbeke M, Flactif M, Lai JL, Hecquet B, Coppin MC, Nelken B, Gosselin B and Fenaux P. (1995). J. Clin. Oncol., 13, 812-820.
43. Ramqvist T, Magnusson KP, Wang Y, Szekely L, Klein G and Wiman KG. (1993). Oncogene, 8, 1495-1500.
44. Reifenberger G, Liu L, Ichimura K, Schmidt EE and Collins VP. (1993). Cancer Res., 53, 2736-2739.
45. Sheikh MS, Shao ZM, Hussain A and Fontana JA. (1993). Cancer Res., 53, 3226-3228.
46. Vogelstein B and Kinzler KW. (1992). Cell, 70, 523-526.
47. Vousden KH, Crook T and Farrell PJ. (1993). J. Gen. Virol., 74, 803-810.
48. Wattel E, Preudhomme C, Hecquet B, Vanrumbeke M, Quesnel B, Dervite I, Morel P and Fenaux P. (1994). Blood, 84, 3148-3157.
49. Wiman KG, Magnusson KP, Ramqvist T and Klein G. (1991). Oncogene, 6, 1633-1639.
50. Wu X, Bayle JH, Olson D and Levine AJ. (1993). Genes Dev., 7, 1126-1132.
51. Xiao ZX, Chen J, Levine AJ, Modjtahedi N, Xing J, Sellers WR and Livingston DM. (1995). Nature, 375, 694-698.
52. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A and Oren M. (1991). Nature, 352, 345-347.
53. Zhou M, Yeager AM, Smith SD and Findley HW. (1995). Blood, 85, 1608-1614.